USD 14.0
(0.72%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 11.27 Million | 11.52 Million | 6.94 Million | 9.4 Million | 7.18 Million | 7.92 Million |
Net Income | 3.53 Million | 8.58 Million | 7.63 Million | 4.5 Million | 7.08 Million | 6.43 Million |
Depreciation & Amortization | 614 Thousand | 642 Thousand | 702 Thousand | 749 Thousand | 627 Thousand | 588 Thousand |
Deferred income taxes | -37 Thousand | 249 Thousand | 838 Thousand | -241 Thousand | 94 Thousand | -337 Thousand |
Stock-based compensation | 1.19 Million | 825 Thousand | 367 Thousand | 664 Thousand | 736 Thousand | 765 Thousand |
Change in working capital | 92 Thousand | -2.17 Million | -4.06 Million | 1.46 Million | -1.45 Million | 63 Thousand |
Other non-cash items | -3.53 Million | 3.4 Million | 1.47 Million | 2.27 Million | 96 Thousand | 412 Thousand |
Investing Cash Flow | -49.25 Million | -18.61 Million | -189.86 Million | -136.26 Million | -18.51 Million | -54.51 Million |
Investments in PPE | -443 Thousand | - | -45 Thousand | -1.56 Million | -642 Thousand | -367 Thousand |
Acquisitions | - | - | - | - | - | 1.74 Million |
Investment purchases | -3.3 Million | -68.06 Million | -305.59 Million | -96.99 Million | -10.68 Million | -7.66 Million |
Sales/Maturities of investments | 16.72 Million | 51.16 Million | 73.35 Million | 58.18 Million | 16.02 Million | 11.4 Million |
Other Investing Activities | -62.22 Million | -1.71 Million | 42.41 Million | -95.89 Million | -23.2 Million | -59.63 Million |
Financing Cash Flow | 38.23 Million | -38.97 Million | 160.23 Million | 181.26 Million | 11.58 Million | 34.71 Million |
Debt repayment | -10 Million | - | -5 Million | -5 Million | - | - |
Dividends payments | - | - | - | - | -3000.00 | -7000.00 |
Common Stock Repurchased | - | -2.51 Million | -253 Thousand | - | - | - |
Common Stock Issuance | - | - | - | - | 15 Thousand | 301 Thousand |
Other Financing Activities | - | -36.46 Million | 165.48 Million | 186.26 Million | 11.57 Million | 34.72 Million |
Accounts receivables | - | 69 Thousand | -1.21 Million | -514 Thousand | 27 Thousand | -232 Thousand |
Accounts payables | 409 Thousand | 7000.00 | -8000.00 | -29 Thousand | 11 Thousand | 30 Thousand |
Inventory | - | -69 Thousand | 1.21 Million | 514 Thousand | -27 Thousand | - |
Other working capital | 24 Thousand | -2.17 Million | -4.05 Million | 1.49 Million | -1.46 Million | 33 Thousand |
Cash at beginning of period | 38.01 Million | 84.07 Million | 106.76 Million | 52.35 Million | 52.1 Million | 63.97 Million |
Cash at end of period | 38.26 Million | 38.01 Million | 84.07 Million | 106.76 Million | 52.35 Million | 52.1 Million |
Capital Expenditure | -443 Thousand | - | -45 Thousand | -1.56 Million | -642 Thousand | -367 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 254 Thousand | -46.06 Million | -22.68 Million | 54.41 Million | 252 Thousand | -11.87 Million |
Free Cash Flow | 10.82 Million | 11.52 Million | 6.9 Million | 7.84 Million | 6.54 Million | 7.55 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 894 Thousand | 901 Thousand | 677 Thousand | 3.53 Million | 935 Thousand | 609 Thousand |
Depreciation & Amortization | - | - | - | 614 Thousand | - | - |
Deferred income taxes | - | - | - | -37 Thousand | - | - |
Stock-based compensation | - | - | - | 1.19 Million | - | - |
Change in working capital | - | - | - | 92 Thousand | - | - |
Other non-cash items | -894 Thousand | -901 Thousand | -677 Thousand | -3.53 Million | -935 Thousand | -609 Thousand |
Investing Cash Flow | - | - | - | -49.25 Million | - | - |
Investments in PPE | - | - | - | -443 Thousand | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | -3.3 Million | - | - |
Sales/Maturities of investments | - | - | - | 16.72 Million | - | - |
Other Investing Activities | - | - | - | -62.22 Million | - | - |
Financing Cash Flow | - | - | - | 38.23 Million | - | - |
Debt repayment | - | - | - | -10 Million | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | 409 Thousand | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | 24 Thousand | - | - |
Cash at beginning of period | - | - | - | 38.01 Million | - | - |
Cash at end of period | - | - | - | 38.26 Million | - | - |
Capital Expenditure | - | - | - | -443 Thousand | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | 254 Thousand | - | - |
Free Cash Flow | - | - | - | 10.82 Million | - | - |
BAJAJHCARE
POLYMED
IFSUF
SHINEFASH
3417
0295